United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$173Mraised across 4 rounds since 2015, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recorded
Deerfield
Invus
ArrowMark PartnersReported by GlobenewswireSEC filing: $65M sold, first sale Jun 2018
Reported by FinSMEsSEC filing: $22M sold, first sale Nov 2017
From a historical funding recordSEC filing: $12M sold, first sale Jan 2015
From the SEC filings it signed: 2 on the team.
On the board, as filediAmir NashatCarol GallagherKristina BurowRichard HeymanRobert AdelmanRonald Evans
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Polaris Partners
ARCH Venture Partners
venBio PartnersVenrock Healthcare Partners/ Franklin TempletonL
New Enterprise AssociatesDeerfield
Franklin TempletonInvus
Vivo CapitalLilly Asia VenturesMissing a round, or an investor who was in one? Tell us.
These 2 firms list Metacrine as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.
Metacrine's investors include Polaris Partners, ARCH Venture Partners, venBio Partners, Venrock Healthcare Partners/ Franklin Templeton and New Enterprise Associates, and 11 more on record.
Metacrine has raised $173M across 4 rounds since 2015.
Metacrine's most recent round was a Debt of $50M in Sept 2019.
Metacrine's largest round on record is $65M (Series C), in Jun 2018, led by Venrock Healthcare Partners/ Franklin Templeton.
Metacrine's first round on record, in Aug 2015, was backed by Polaris Partners, ARCH Venture Partners and EcoR1 Capital and 1 others.
Metacrine's latest named round is a Debt, in Sept 2019.
Metacrine is based in the United States.
Venrock Healthcare Partners/ Franklin Templeton led the Series C in 2018.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
